Treatment of hypothyroidism in elderly patients and in patients with cardiac disease

Related Experiment Videos

Ulla Feldt-Rasmussen1

  • 1Department of Medical Endocrinology, Rigshospitalet, National University Hospital, Copenhagen, Denmark. ufeldt@rh.dk

Insights

Hypothyroidism poses cardiovascular risks, including high cholesterol and hypertension. Levothyroxine replacement therapy requires careful initiation, especially in elderly patients with unstable angina, to prevent cardiac events.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Hypothyroidism is linked to cardiovascular risks like hypertension, high cholesterol, and endothelial dysfunction.
  • Hemodynamic changes in hypothyroidism include reduced cardiac index and impaired renal perfusion.
  • Ischemic abnormalities may stem from long-term hypothyroidism, while hemodynamic changes can occur acutely.

Purpose of the Study:

  • To review the cardiovascular implications of hypothyroidism.
  • To discuss the effects of levothyroxine replacement therapy on cardiovascular health.
  • To provide guidance on managing hypothyroidism in patients with cardiovascular disease.

Main Methods:

  • Literature review of studies on hypothyroidism and cardiovascular disease.
  • Analysis of hemodynamic and metabolic changes associated with hypothyroidism.
  • Evaluation of levothyroxine replacement strategies in hypothyroid patients with cardiac conditions.

Main Results:

  • Levothyroxine replacement normalizes basal metabolic rate and can improve angina symptoms.
  • Initial levothyroxine therapy may precipitate or worsen cardiac ischemia in some patients.
  • Elderly patients with unstable angina require careful management during levothyroxine initiation.

Conclusions:

  • Hypothyroidism presents significant cardiovascular risks that necessitate careful management.
  • Levothyroxine therapy should be initiated cautiously, with potential need for cardiac evaluation and monitoring.
  • Individualized treatment strategies are crucial for hypothyroid patients with cardiovascular disease, particularly the elderly.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...